Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 358.00
-2.00 (-0.56%)
Oct 10, 2025, 5:07 PM GMT+1
Tristel Market Cap
Tristel has a market cap or net worth of 170.86 million as of October 10, 2025. Its market cap has decreased by -9.45% in one year.
Market Cap
170.86M
Enterprise Value
165.08M
Revenue
43.56M
Ranking
n/a
PE Ratio
27.79
Stock Price
358.00
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 170.86M, an increase of 2,373.66%. That is a compound annual growth rate of 17.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 170.86M | -15.71% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | 245.16M | 42.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.21B |
| GSK plc | 65.38B |
| Haleon | 30.16B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.02B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.68B |